These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1394602)

  • 1. [Short-term effect and the mechanism of radix Angelicae on pulmonary hypertension in chronic obstructive pulmonary disease].
    Zheng L
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Apr; 15(2):95-7, 127. PubMed ID: 1394602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of diprophylline on pulmonary hypertension in patients with chronic pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Jun; 15(3):153-4, 190. PubMed ID: 1473187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of thromboxane A2 (TXA2) and prostacyclin (PGI2) in COPD patients with pulmonary hypertension].
    Zheng L; Duan SF; Zhang ZX
    Zhonghua Nei Ke Za Zhi; 1991 Feb; 30(2):91-3, 126. PubMed ID: 1864178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dilative effect of injection of radix Angelicae, Salvia miltiorrhiza and ligustrazin on the pulmonary vessels in rats].
    Sun RY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Feb; 10(1):40-4. PubMed ID: 2968176
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic and respiratory effects of phentolamine in pulmonary hypertension secondary to chronic obstructive syndrome].
    Domenighetti G; Leuenberger P; Perret C
    Schweiz Med Wochenschr; 1985 Jan; 115(3):99-103. PubMed ID: 3975579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment.
    Lampert E; Tuo N; Frans A; Lonsdorfer J
    Pathol Biol (Paris); 1991 Jan; 39(1):29-33. PubMed ID: 2011406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blockers of angiotensin receptors: a novel approach to the treatment of secondary pulmonary hypertension].
    Butorov IV; Verbitskiĭ ON; Butorov SI
    Ter Arkh; 2004; 76(6):84-7. PubMed ID: 15332584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostaglandin E1 (PGE1) in pulmonary hypertension due to chronic obstructive pulmonary disease (COPD).
    Meissner E; Creutzig A; Fabel H
    Prog Clin Biol Res; 1989; 301():253-7. PubMed ID: 2798450
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of pulmonary hypertension in chronic obstructive pulmonary diseases.
    Weitzenblum E; Mammosser M; Ehrhart M
    G Ital Cardiol; 1984; 14 Suppl 1():33-8. PubMed ID: 6534764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on the influence of radix Angelicae sinensis upon pulmonary circulation in rats].
    Sun RY
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Jun; 11(3):163-6, 192. PubMed ID: 2851392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
    Gassner A
    Schweiz Med Wochenschr; 1984 Mar; 114(10):332-7. PubMed ID: 6710104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of renin-angiotensin system in pathogenesis of pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Frangulian RR
    Klin Med (Mosk); 2000; 78(10):18-20. PubMed ID: 11220892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration].
    Liu Z; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.
    Bertoli L; Fusco M; Lo Cicero S; Micallef E; Busnardo I
    Postgrad Med J; 1986; 62 Suppl 1():47-51. PubMed ID: 3022273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary hypertension in chronic lung diseases].
    Chereĭskaia NK
    Gig Tr Prof Zabol; 1991; (9):11-4. PubMed ID: 1794713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of hemorrheology in COPD patients with or without cor pulmonale].
    Wang TS
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):228-9, 255. PubMed ID: 2636949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of molsidomine on pulmonary circulation of patients with chronic obstructive pulmonary disease.
    Mwepu AK; Lampert E; Frans A
    Pathol Biol (Paris); 1989 Dec; 37(10):1133-6. PubMed ID: 2608319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.